Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III multicenter open-label study of STSP-0601 for on-demand treatment of bleeding in hemophilia patients with inhibitors
CTR20250843Phase 3Active
- Sponsor
- Staidson Biopharmaceutical
- Start
- Mar 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of bemiltenase alfa in hemophilia A, hemophilia B (HB), sponsored by Staidson Biopharmaceutical. Started Mar 2025; status: active.
02
Drugs
bemiltenase alfa
03
Conditions
hemophilia Ahemophilia B (HB)
Beyond the preview
Go deeper on CTR20250843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250843.